About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Keyed! Latest Therapeutic Target Against Atherosclerosis

by Nancy Needhima on December 16, 2011 at 8:31 PM
Font : A-A+

Keyed! Latest Therapeutic Target Against Atherosclerosis

A feasible new therapy target against atherosclerosis resulting from a diet high in fat and cholesterol has been identified by scientists.

The researchers from Boston University School of Medicine (BUSM) have identified for the first time the A2b adenosine receptor (A2bAR) as an agent responsible for protection against early stages of atherosclerosis.

Advertisement

Adenosine is a metabolite produced naturally by cells at low levels, and at higher levels during exercise or stress.

Adenosine binds to and activates cell surface receptors, one of which is the A2bAR. Previous studies have described the A2bAR as anti-inflammatory and protective against kidney ischemia, cardiac reperfusion injury and restenosis, typically via bone marrow cell signals.
Advertisement

In mouse models, BUSM researchers found atherosclerosis induced by a high-fat diet was more pronounced in the absence of the A2bAR.

They also found bone marrow transplantation experiments indicated that A2bAR bone marrow cell signals alone were not sufficient to elicit this effect.

"A2bAR genetic ablation led to elevated levels of liver and plasma cholesterol and triglycerides, and to fatty-liver pathology typical of steatosis, assessed by enzymatic assays and analysis of liver sections," explained senior author Katya Ravid, MD, a professor of medicine and biochemistry at BUSM.

The researchers also identified the mechanism underlying this effect in the liver, involving the control of the transcription factor SREBP-1 and its downstream targets-regulators of lipid synthesis.

They found restoration of the A2bAR in the liver of A2bAR null mice reduced the lipid profile and atherosclerosis.

"Most importantly, in vivo administration of a pharmacological activator of the A2bAR in control mice on a high fat diet reduced lipid profile and atherosclerosis," Ravid said

"Thus, this study provides the first evidence that the A2bAR regulates liver hyperlipidemia and atherosclerosis, suggesting that this receptor may be an effective therapeutic target against earlier stages of atherosclerosis," she concluded.

The findings appeared on-line in Circulation.

Source: ANI
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test Your Knowledge About Chromosomes?
Eating During Sunlight Hours Minimizes Mood Vulnerabilities
Know More About the Digestive System
View all
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

Most Popular on Medindia

Find a Doctor Drug - Food Interactions Nutam (400mg) (Piracetam) Diaphragmatic Hernia Indian Medical Journals A-Z Drug Brands in India Find a Hospital Noscaphene (Noscapine) Daily Calorie Requirements Blood Pressure Calculator
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Keyed! Latest Therapeutic Target Against Atherosclerosis Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests